Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

897
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
897
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

1.7K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.7K
Renal Corpuscle01:20

Renal Corpuscle

8.5K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
8.5K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

314
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
314
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

3.3K
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HER2 In Situ Hybridization: Validation and Implementation of Brightfield Assay in a US Academic Pathology Laboratory.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same author

Reporting of both positive and negative concordance is necessary to recognise and investigate bias in digital algorithms.

Journal of clinical pathology·2026
Same author

Repurposing HER2 IHC: Pan-HER2 and Low-HER2.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same author

TRPS1 Expression Across the Spectrum of Paget Disease and Morphologic Mimics.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same author

Immunohistochemistry New Instrument Validations: Why Your Validation Plan Matters.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same author

Rifampin-induced Acute Kidney Injury Is Associated With Hemolysis and Drug Re-exposure.

Kidney medicine·2026

Related Experiment Video

Updated: Mar 24, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.0K

Atypical anti-glomerular basement membrane disease.

Megan L Troxell1, Donald C Houghton1

  • 1Department of Pathology , Oregon Health & Science University , Portland, OR , USA.

Clinical Kidney Journal
|March 18, 2016
PubMed
Summary

Atypical anti-glomerular basement membrane (anti-GBM) disease presents subtly, with some cases lacking detectable antibodies. Close monitoring of patients with atypical anti-GBM disease on renal biopsy is crucial for timely intervention.

Keywords:
Goodpasture'santi-glomerular basement membrane diseasecrescentic glomerulonephritis

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.9K
Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

11.2K

Related Experiment Videos

Last Updated: Mar 24, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.0K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.9K
Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis
06:56

Antibody Transfection into Neurons as a Tool to Study Disease Pathogenesis

Published on: September 26, 2012

11.2K

Area of Science:

  • Nephrology
  • Immunopathology
  • Glomerular Diseases

Background:

  • Anti-glomerular basement membrane (anti-GBM) disease is characterized by aggressive glomerulonephritis and pulmonary hemorrhage.
  • Pathologically, it shows linear immunoglobulin G (IgG) deposition in glomerular basement membranes (GBMs) and circulating autoantibodies against GBM collagen IV alpha-3.

Purpose of the Study:

  • To identify and characterize cases of anti-GBM disease with atypical or indolent clinical and pathological presentations.
  • To highlight the importance of thorough clinicopathologic evaluation and vigilant follow-up for these rare cases.

Main Methods:

  • Retrospective review of renal pathology files for cases with linear anti-GBM staining.
  • Detailed analysis of histopathology, laboratory findings, treatment, and patient outcomes.

Main Results:

  • Five cases (approximately 8% of anti-GBM cases) exhibited atypical features, including minimal glomerular changes on light microscopy.
  • Three patients lacked detectable serum anti-GBM antibodies by standard assays, and three had indolent courses post-immunosuppression.
  • One untreated patient initially presenting with mild hematuria later developed severe necrotizing and crescentic glomerulonephritis.

Conclusions:

  • Atypical anti-GBM disease requires comprehensive clinicopathologic assessment and close patient follow-up.
  • Literature review indicates that well-documented atypical anti-GBM cases are rare, with a low progression rate to end-stage kidney disease.